JPRN-UMIN000013738招募中未知
Multicenter cohort study for Investigating Dystophinopathy-associated CArdiovascuLar Failure in Japan - MIDCALF-J
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients without definitive diagnosis. Patients' refusal to participate.
研究者
相似试验
已完成
不适用
Multicenter retrospective observational study of data of cancer clinical sequence assay, MSK-IMPACTSolid malignant tumorJPRN-UMIN000031407Yokohama City University50
招募中
1 期
[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancerMedDRA version: 20.0Level: PTClassification code: 10060862Term: Prostate cancer Class: 100000004864Prostate CancerCTIS2023-504026-19-01Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH360
已完成
不适用
ationwide Cohort study on the development of diagnosis and treatment of pheochromocytoma in JapaPheochromocytomaJPRN-UMIN000004151Ministry of Health, Labour and Welfare , The Japan Endocrine Society2,500
进行中（未招募）
不适用
A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Men with Hormone-Refractory Prostate Cancer.Treatment of bone metastases in men with hormone- refractory prostate cancer.EUCTR2006-000341-19-DEAmgen Inc1,870
进行中（未招募）
不适用
A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects with Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple MyelomaTreatment of bone metastases in subjects with advanced cancer (excluding breast and prostate cancer) or multiple myelomaEUCTR2006-000848-65-PTAmgen Inc1,690